ROSWELL PARK DNA REPLICATION PROGRAM FACILITIES
ROSWELL PARK DNA REPLICATION PROGRAM FACILITIES
批准号:
6424358
负责人:
YOUCEF B RUSTUM
金额:
$200.0万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-15 至 2005-02-14
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by applicant): RPCI is nearing completion of a major
modernization program that will replace or renovate nearly all the buildings
on its 25-acre campus by the year 2002. Recent construction has made it
possible to vacate a large amount of space in the Cell and Virus Building in
preparation for the expansion of the Center for Cancer Genetics. Many of the
investigators who remain in this building are members of the DNA Replication
Program, which is an integral component of the Center for Cancer Genetics.
The research focus of this highly interactive group of scientists is on
aspects of DNA replication that intersect with the problem of cancer and how
to effectively treat this disease. This unique program capitalizes on the
unusually large amount of expertise in the field of DNA replication at RPCI
and other academic institutions in the Buffalo area. The funds requested in
this application will be used to renovate the second and third floors of the
six-story Cell and Virus Building for occupancy by these investigators, whose
programs are now housed on four different floors. With the appointment of
John Cowell, Ph.D., as Chair of the Department of Cancer Genetics in 2000, an
additional four recruits are anticipated into this program. Consolidation of
the research activities of Program members into contiguous space will
facilitate collaborations and allow for the renovation of the remaining floors
of the building with other funds to eventually provide laboratory space for
the expanded Center for Cancer Genetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irinotecan in Combination with Celecoxib
-
批准号:6737837
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2003
-
负责人:YOUCEF B RUSTUM
-
依托单位:
ROSWELL PARK MOUSE MOLECULAR GENETICS PROGRAM FACILITIES
-
批准号:2722177
-
项目类别:
-
资助金额:$74.7万
-
财政年份:1998
-
负责人:YOUCEF B RUSTUM
-
依托单位:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
-
批准号:6172382
-
项目类别:
-
资助金额:$27.76万
-
财政年份:1995
-
负责人:YOUCEF B RUSTUM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Park7激活Nrf2/HO-1通路抑制铁死亡,缓解ONC模型中RGCs损伤的机制研究
-
批准号:JCZRQNB202600263
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SERCA2通过PARK7-ROS抑制铁死亡减轻肾纤维化的机制研究
-
批准号:2026JJ60647
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕昕
-
依托单位:
CircGLIS3通过调控YY1/PARK7轴抑制乳腺癌中铁死亡发生的机制研究
-
批准号:2026JJ82239
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭小浪
-
依托单位:
棕色脂肪外泌体miR-23a靶向调控PARK2/PGC1α轴抑制非酒精性脂肪肝病进展的机制研究
-
批准号:JCZRQN202501149
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
西红花酸调控PARK7/Drp1/Atp5g3介导的血管内皮线粒体-铁死亡途径抗动脉粥样硬化共抑郁的作用机制
-
批准号:QN25H280026
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李兰
-
依托单位:
PPM1B降低PARK7蛋白稳定性促进DNA氧化损伤以抑制肝细胞癌耐药的机制研究
-
批准号:2025JJ50488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:盛朗晴
-
依托单位:
TRIM44通过PINK1-PARK2调控线粒体自噬参与肾脏缺血再灌注损伤诱导的急性肾损伤
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
右美托咪定通过SIRT3激活PINK1/Park2通路促进线粒体自噬改善脓毒症急性肾损伤的机制研究
-
批准号:2024Y9114
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:廖秋霞
-
依托单位:
BAX介导mitolysosome形成在PARK2突变帕金森病中的产生及其作用机制研究
-
批准号:32371007
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:包飞翔
-
依托单位:
PARK7调控线粒体适应性反应在缺血性AKI中的作用和机制研究
-
批准号:2023JJ30782
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:唐程远
-
依托单位: